Bank of Montreal’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-188
Closed -$87K 5337
2020
Q4
$87K Hold
188
﹤0.01% 3663
2020
Q3
$74K Hold
188
﹤0.01% 3246
2020
Q2
$92K Sell
188
-28
-13% -$12.5K ﹤0.01% 3133
2020
Q1
$77K Sell
216
-261
-55% -$135K ﹤0.01% 2719
2019
Q4
$337K Buy
477
+216
+83% +$149K ﹤0.01% 2880
2019
Q3
$167K Hold
261
﹤0.01% 3020
2019
Q2
$228K Sell
261
-420
-62% -$289K ﹤0.01% 2851
2019
Q1
$393K Sell
681
-406
-37% -$170K ﹤0.01% 2405
2018
Q4
$305K Buy
1,087
+515
+90% +$204K ﹤0.01% 2387
2018
Q3
$275K Buy
572
+167
+41% +$71.6K ﹤0.01% 2595
2018
Q2
$184K Sell
405
-60
-13% -$38K ﹤0.01% 2808
2018
Q1
$274K Sell
465
-619
-57% -$386K ﹤0.01% 2483
2017
Q4
$673K Buy
1,084
+47
+5% +$33.8K ﹤0.01% 2147
2017
Q3
$955K Sell
1,037
-262
-20% -$233K ﹤0.01% 1998
2017
Q2
$1.21M Sell
1,299
-114
-8% -$112K ﹤0.01% 1900
2017
Q1
$1.34M Buy
1,413
+603
+74% +$561K ﹤0.01% 1743
2016
Q4
$787K Sell
810
-109
-12% -$98.2K ﹤0.01% 1975
2016
Q3
$776K Buy
919
+26
+3% +$20.9K ﹤0.01% 1922
2016
Q2
$736K Buy
893
+63
+8% +$68.6K ﹤0.01% 1969
2016
Q1
$924K Buy
+830
New +$849K ﹤0.01% 1789

Other funds holding TCRT

Bank of Montreal's TCRT Position: Q1 2024 in Review

Bank of Montreal sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 134 shares — an estimated $1.54K sold.

Bank of Montreal first reported a position in TCRT in Q2 2014 and held it in 32 quarters. The position peaked at $1.36M in Q1 2017. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.

  • Bank of Montreal reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Bank of Montreal sold 134 Alaunos Therapeutics shares in Q1 2024, an estimated $1.54K.
  • Bank of Montreal first reported a position in Alaunos Therapeutics in Q2 2014 and held it in 32 quarters.
  • Bank of Montreal's Alaunos Therapeutics position peaked at $1.36M in Q1 2017.
  • 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.

Based on Bank of Montreal's 13F filing for Q1 2024, filed 13 May 2024.